Skip to content

Clinical trials

Gliosarcoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gliosarcoma Clear all

487 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200026
200123
200231
200312
200421
200534
200629
200732
200828
200927
201028
201115
201213
201316
201411
201512
20168
20179
20187
20197
20207
20214
20224
20235
20242
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed340
Terminated70
Unknown status22
Active, not recruiting20
Withdrawn19
Recruiting12
Suspended2
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)94
Duke University37
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins34
M.D. Anderson Cancer Center22
Jonsson Comprehensive Cancer Center15
European Organisation for Research and Treatment of Cancer - EORTC13
City of Hope Medical Center11
Case Comprehensive Cancer Center10
Memorial Sloan Kettering Cancer Center10
Radiation Therapy Oncology Group10

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gliosarcoma487
Glioblastoma476
Brain Neoplasms272
Astrocytoma230
Central Nervous System Neoplasms223
Glioma191
Oligodendroglioma176
Ependymoma77
Medulloblastoma42
Neuroectodermal Tumors, Primitive42

Trials

Showing 76 to 100 of 487. Each trial links to its page on Pharma Observatory.

387 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.